The primary risk factors for developing MPNST rely on existing plexiform neurofibromas (PN), histologically benign tumors, which develop from Schwann cell biallelic NF1 inactivation occurring in nearly 30–50% of NF1 patients [1,5,7,8]. The gene discussed is NF1; the disease is plexiform neurofibroma.